BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	156,180.94 423.57M	0.51% 796.43
ALLSHR	95,690.82 1,354.89M	0.59% 557.25
KSE30	47,714.39 199.12M	0.52% 247.40
KMI30	229,722.09 134.66M	0.91% 2076.87
KMIALLSHR	64,420.07 581.33M	0.83% 532.01
BKTi	41,969.52 122.61M	0.50% 207.74
OGTi	31,991.76 10.82M	1.18% 372.62

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	115,245.00	116,415.00 115,085.00	-330.00 -0.29%
BRENT CRUDE	68.14	68.28 67.01	0.70 1.04%
RICHARDS BAY COAL MONTHLY	84.00	0.00 0.00	-0.40 -0.47%
ROTTERDAM COAL MONTHLY	93.40	93.50 93.15	0.55 0.59%
USD RBD PALM OLEIN	1,106.50	1,106.50 1,106.50	0.00 0.00%
CRUDE OIL - WTI	64.17	64.31 62.89	0.87 1.37%
SUGAR #11 WORLD	15.85	16.10 15.83	-0.15 -0.94%